Forest Pins Orapem Hopes On Double Indication For Sinusitis, Pneumonia
Executive Summary
Forest Labs believes the successful launch of its antibiotic Orapem (faropenem) hinges on receiving approval for at least two indications
You may also be interested in...
Forest Former Chief Scientific Officer Olanoff Returns As President And COO
Lawrence Olanoff will return to Forest Labs as president and chief operating officer following the departure of current President and COO Kenneth Goodman, the company announced Sept. 7
Forest Former Chief Scientific Officer Olanoff Returns As President And COO
Lawrence Olanoff will return to Forest Labs as president and chief operating officer following the departure of current President and COO Kenneth Goodman, the company announced Sept. 7
Forest Replants Combunox Sales Force For Pending Beta-Blocker Nebivolol
Forest's plans to distinguish its marketed antihypertensive Benicar and the pending nebivolol include detailing the two products with separate sales forces